Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis
暂无分享,去创建一个
J. D. Di Battista | Yang Zhao | Stephan Hasse | Chenqi Zhao | S. Bourgoin | É. Boilard | P. Poubelle | Myriam Vaillancourt | P. Fortin | Lynn Davis
[1] Chien-Chin Chen,et al. Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials , 2021, Cells.
[2] Yang Zhao,et al. Phosphatidylserine-specific phospholipase A1: A friend or the devil in disguise. , 2021, Progress in lipid research.
[3] K. Hasegawa,et al. Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma , 2020, Scientific Reports.
[4] M. Kurano,et al. Elevated phosphatidylserine-specific phospholipase A1 level in hyperthyroidism. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[5] T. Sawada,et al. Serum phosphatidylserine‐specific phospholipase A1 as a novel biomarker for monitoring systemic lupus erythematosus disease activity , 2019, International journal of rheumatic diseases.
[6] Yang Zhao,et al. Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases. , 2019, Biochemical pharmacology.
[7] Hsinyu Lee,et al. Mechanisms of Lysophosphatidic Acid-Mediated Lymphangiogenesis in Prostate Cancer , 2018, Cancers.
[8] Z. Zeng,et al. Blocking of YY1 reduce neutrophil infiltration by inhibiting IL‐8 production via the PI3K‐Akt‐mTOR signaling pathway in rheumatoid arthritis , 2018, Clinical and experimental immunology.
[9] S. M. Kim,et al. Lysophosphatidylserine receptor P2Y10: A G protein‐coupled receptor that mediates eosinophil degranulation , 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[10] A. Fish,et al. Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency , 2018, The Journal of Biological Chemistry.
[11] M. Kurano,et al. Association between serum autotaxin or phosphatidylserine‐specific phospholipase A1 levels and melanoma , 2018, The Journal of dermatology.
[12] Silvia Anahi Valdés-Rives,et al. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development , 2017, Mediators of inflammation.
[13] Takafumi N. Yamaguchi,et al. TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer , 2017, Nature Genetics.
[14] M. Kurano,et al. Analysis of glycero-lysophospholipids in gastric cancerous ascites[S] , 2017, Journal of Lipid Research.
[15] X. Jouven,et al. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection , 2017, Circulation.
[16] H. Daida,et al. Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome[S] , 2017, Journal of Lipid Research.
[17] M. Bootman,et al. Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells , 2016, Journal of Cell Science.
[18] J. Christman,et al. Polyunsaturated lysophosphatidic acid as a potential asthma biomarker. , 2016, Biomarkers in medicine.
[19] H. Daida,et al. Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids , 2015, BBA clinical.
[20] J. Cyster,et al. The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function , 2015, The Journal of experimental medicine.
[21] D. Brindley,et al. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate[S] , 2015, Journal of Lipid Research.
[22] M. Kurano,et al. Lysophosphatidylserine has Bilateral Effects on Macrophages in the Pathogenesis of Atherosclerosis. , 2015, Journal of atherosclerosis and thrombosis.
[23] J. Aoki,et al. Phosphatidylserine-specific phospholipase A1 (PS-PLA1) expression in colorectal cancer correlates with tumor invasion and hematogenous metastasis. , 2015, Anticancer research.
[24] Duane D. Miller,et al. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. , 2014, Blood.
[25] J. Aoki,et al. Novel lysophosphoplipid receptors: their structure and function , 2014, Journal of Lipid Research.
[26] S. Georas,et al. The Autotaxin–LPA Axis Emerges as a Novel Regulator of Lymphocyte Homing and Inflammation , 2014, The Journal of Immunology.
[27] C. Leslie,et al. Neutrophils Regulate Tissue Neutrophilia in Inflammation via the Oxidant-modified Lipid Lysophosphatidylserine* , 2013, The Journal of Biological Chemistry.
[28] D. Bratton,et al. Emerging roles for lysophosphatidylserine in resolution of inflammation. , 2012, Progress in lipid research.
[29] Anastassis Perrakis,et al. Insights into autotaxin: how to produce and present a lipid mediator , 2011, Nature Reviews Molecular Cell Biology.
[30] Tao Wu,et al. Binding of Autotaxin to Integrins Localizes Lysophosphatidic Acid Production to Platelets and Mammalian Cells* , 2011, The Journal of Biological Chemistry.
[31] D. Baker,et al. The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation[S] , 2011, Journal of Lipid Research.
[32] H. Nishimasu,et al. Crystal structure of autotaxin and insight into GPCR activation by lipid mediators , 2011, Nature Structural &Molecular Biology.
[33] N. Hayashi,et al. A novel enzyme immunoassay for the determination of phosphatidylserine-specific phospholipase A(1) in human serum samples. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[34] Chenqi Zhao,et al. Autotaxin and lysophospholipids in rheumatoid arthritis. , 2010, Current opinion in investigational drugs.
[35] G. Mills,et al. Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and Thrombosis* , 2009, Journal of Biological Chemistry.
[36] J. Aoki,et al. Two pathways for lysophosphatidic acid production. , 2008, Biochimica et biophysica acta.
[37] G. Prestwich,et al. Regulation of Lysophosphatidic Acid Receptor Expression and Function in Human Synoviocytes: Implications for Rheumatoid Arthritis? , 2008, Molecular Pharmacology.
[38] A. Koch. The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.
[39] W. Moolenaar,et al. Regulation and biological activities of the autotaxin-LPA axis. , 2007, Progress in lipid research.
[40] H. Arai,et al. Structure and function of extracellular phospholipase A1 belonging to the pancreatic lipase gene family. , 2007, Biochimie.
[41] M. Ebisawa,et al. Identification of a lysophosphatidylserine receptor on mast cells. , 2006, Biochemical and biophysical research communications.
[42] K. Kikuchi,et al. Inhibition of Autotaxin by Lysophosphatidic Acid and Sphingosine 1-Phosphate* , 2005, Journal of Biological Chemistry.
[43] A. Koch. Chemokines and their receptors in rheumatoid arthritis: future targets? , 2005, Arthritis and rheumatism.
[44] J. Aoki. Mechanisms of lysophosphatidic acid production. , 2004, Seminars in cell & developmental biology.
[45] Yoshiya Tanaka,et al. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts. , 2004, Arthritis and rheumatism.
[46] R. Taguchi,et al. Biochemical and Molecular Characterization of Two Phosphatidic Acid-selective Phospholipase A1s, mPA-PLA1α and mPA-PLA1β* , 2003, Journal of Biological Chemistry.
[47] R. Taguchi,et al. Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways* , 2002, The Journal of Biological Chemistry.
[48] G. Mills,et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.
[49] H. Arai,et al. Structure and function of phosphatidylserine-specific phospholipase A1. , 2002, Biochimica et biophysica acta.
[50] R. Taguchi,et al. Phosphatidylserine-specific Phospholipase A1Stimulates Histamine Release from Rat Peritoneal Mast Cells through Production of 2-Acyl-1-lysophosphatidylserine* , 2001, The Journal of Biological Chemistry.
[51] Y. Ohkawa,et al. Phenotypic Modulation of Vascular Smooth Muscle Cells Induced by Unsaturated Lysophosphatidic Acids , 2001, Circulation research.
[52] H. Arai,et al. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species , 2000, FEBS letters.
[53] L. Joosten,et al. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis , 1999, Arthritis research.
[54] Hiroyuki Arai,et al. An Alternative Splicing Form of Phosphatidylserine-specific Phospholipase A1 That Exhibits Lysophosphatidylserine-specific Lysophospholipase Activity in Humans* , 1999, The Journal of Biological Chemistry.
[55] M. Egmond,et al. nmd, a novel gene differentially expressed in human melanoma cell lines, encodes a new atypical member of the enzyme family of lipases , 1997, FEBS letters.
[56] Hiroyuki Arai,et al. Serine Phospholipid-specific Phospholipase A That Is Secreted from Activated Platelets , 1997, The Journal of Biological Chemistry.
[57] S. Tanaka,et al. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. , 1994, The American journal of physiology.
[58] L. Liotta,et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.